- Biotechnology
- Healthcare
Incyte Corporation
INCY · US ·
NASDAQ
57.6814
USD
+0.3514
(0.61%)
-
3.32
EPS
-
17.37
P/E
-
13B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 3.53 | 4.59 | 5.9 | 7.06 | 7.45 | 8.53 | 19.30% |
| Avg. Estimate | 3.33 | 4.16 | 4.17 | 5.29 | 7.02 | 8.04 | 19.30% |
| Low Estimate | 3.15 | 3.68 | 3.1 | 3.8 | 6.64 | 7.6 | 19.30% |
| No. Of Analysts | 11 | 13 | 12 | 11 | 4 | 5 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 3.81B | 4.22B | 4.73B | 5.24B | 5.53B | 5.84B | 8.94% |
| Avg. Estimate | 3.77B | 4.08B | 4.5B | 5B | 5.29B | 5.58B | 8.18% |
| Low Estimate | 3.74B | 3.97B | 4.42B | 4.79B | 5.06B | 5.35B | 7.43% |
| No. Of Analysts | 14 | 15 | 17 | 19 | 16 | 8 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 895M | 1.04B | 1.33B | 1.6B | 1.68B | 1.93B | 16.60% |
| Avg. Estimate | 745M | 939M | 955M | 1.21B | 1.59B | 1.82B | 19.51% |
| Low Estimate | 596M | 831M | 700M | 859M | 1.5B | 1.72B | 23.57% |
| No. Of Analysts | 14 | 15 | 17 | 19 | 16 | 8 |